Chapter
An Overview of the Population Studied
An Overview of the Population Studied
Methods of Classifying Polydrug Abusers
Methods of Classifying Polydrug Abusers
Visability of the Patient Population
Visability of the Patient Population
PART 1: Classification and Description of the Polydrug Users
PART 1: Classification and Description of the Polydrug Users
CHAPTER II. Referral Sources and Outreach: Critical Variables in Understanding the Polydrug-Abusing Sample
CHAPTER II. Referral Sources and Outreach: Critical Variables in Understanding the Polydrug-Abusing Sample
Differential Psychosocial Characteristics Related to Referral Source
Differential Psychosocial Characteristics Related to Referral Source
CHAPTER III. Nonpatient Polydrug Users
CHAPTER III. Nonpatient Polydrug Users
CHAPTER IV. Female Polydrug Abusers
CHAPTER IV. Female Polydrug Abusers
Rationale Offered for Sex-Linked Differences in Drug Use Patterns
Rationale Offered for Sex-Linked Differences in Drug Use Patterns
Data on Psychoactive Drug Use and Abuse
Data on Psychoactive Drug Use and Abuse
Subpopulations of Female Population
Subpopulations of Female Population
CHAPTER V. Two Typologies of Polydrug Abusers
CHAPTER V. Two Typologies of Polydrug Abusers
Streetwise and Self-Medication Dimensions
Streetwise and Self-Medication Dimensions
Sex and Streetwise Orientation
Sex and Streetwise Orientation
CHAPTER VI. An Empirical Typology of Multiple Drug Abusers
CHAPTER VI. An Empirical Typology of Multiple Drug Abusers
CHAPTER VII. Dimensions of Polydrug Abuse: An MMPI Study
CHAPTER VII. Dimensions of Polydrug Abuse: An MMPI Study
Classes of Substance Abusers
Classes of Substance Abusers
CHAPTER VIII. Incidence of First Use of Nonopiate Drugs: Inferences from Current Data
CHAPTER VIII. Incidence of First Use of Nonopiate Drugs: Inferences from Current Data
Sampling Problems: The Selectivity of Incidence Data
Sampling Problems: The Selectivity of Incidence Data
Interpretation of Incidence Data: Its Relationship to Drug Abuse
Interpretation of Incidence Data: Its Relationship to Drug Abuse
Empirical First-Use Data from Treatment Programs
Empirical First-Use Data from Treatment Programs
Which Drugs Are Most Abused?
Which Drugs Are Most Abused?
Histories of Misuse: Temporal Sequences and Micro-demographic Differences in Peak Onset
Histories of Misuse: Temporal Sequences and Micro-demographic Differences in Peak Onset
The Progression Hypothesis: Inferences from Incidence Analysis
The Progression Hypothesis: Inferences from Incidence Analysis
A Definitive Incidence Study
A Definitive Incidence Study
CHAPTER IX. Three National Estimates of Prevalence of Nonopiate Drug Abuse
CHAPTER IX. Three National Estimates of Prevalence of Nonopiate Drug Abuse
PART 3: Central Nervous System Consequences of Polydrug Abuse
PART 3: Central Nervous System Consequences of Polydrug Abuse
CHAPTER X. Neuropsychological Effects of Polydrug Abuse
CHAPTER X. Neuropsychological Effects of Polydrug Abuse
Three-Month Follow-Up Evaluation Results
Three-Month Follow-Up Evaluation Results
CHAPTER XI. Neuropsychological Impairment and Psychopathology
CHAPTER XI. Neuropsychological Impairment and Psychopathology
CHAPTER XII. Comparison of Results from Serially Collected Neuropsychological and EEG Data
CHAPTER XII. Comparison of Results from Serially Collected Neuropsychological and EEG Data
Comparison of Halstead-Retain Data with That Obtained by Compressed Spectral Analysis of the EGG
Comparison of Halstead-Retain Data with That Obtained by Compressed Spectral Analysis of the EGG
CHAPTER XIII. Sleep Patterns of Abusers during Titration and Withdrawal from Methaqualone or Secobarbital
CHAPTER XIII. Sleep Patterns of Abusers during Titration and Withdrawal from Methaqualone or Secobarbital
PART 4: Impact of Polydrug Abuse on Nondrug Abuse Health Delivery System
PART 4: Impact of Polydrug Abuse on Nondrug Abuse Health Delivery System
CHAPTER XIV. Physician Attitudes Concerning Drug Abuse Treatment
CHAPTER XIV. Physician Attitudes Concerning Drug Abuse Treatment
Therapeutic Pessimism Scale
Therapeutic Pessimism Scale
Needs in Drug Abuse as Perceived by Physicians
Needs in Drug Abuse as Perceived by Physicians
CHAPTER XV. Response of Traditional Health Care Agencies to Nonopiate Abusers
CHAPTER XV. Response of Traditional Health Care Agencies to Nonopiate Abusers
PART 5: Conclusions and Recommendations
PART 5: Conclusions and Recommendations
CHAPTER XVI. Some Observations on Collaborative Data Management
CHAPTER XVI. Some Observations on Collaborative Data Management
Collaborative Research Projects
Collaborative Research Projects
The Collaborative Group Process
The Collaborative Group Process
The Importance of Record Design
The Importance of Record Design
CHAPTER XVII. Conclusions and Recommendations for Future Research
CHAPTER XVII. Conclusions and Recommendations for Future Research
Polydrug Abuse
：The Results of a National Collaborative Study
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
